{"id":441470,"date":"2021-02-23T05:36:11","date_gmt":"2021-02-23T10:36:11","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441470"},"modified":"2021-02-23T05:36:11","modified_gmt":"2021-02-23T10:36:11","slug":"newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/","title":{"rendered":"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group"},"content":{"rendered":"

<\/p>\n

\nNewly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group\n<\/p>\n

LONDON–(BUSINESS WIRE<\/a>)–
\nKanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited (\u201cAstral Health\u201d). Astral Health is fully owned by LYPHE Group, which is part of Drug Science\u2019s Project Twenty21. According to the agreement, Kanabo will supply its medical-grade inhalation device, VapePod\u00ae and a line of medicinal cannabis formulations in pods for the UK market.\n<\/p>\n

\nThrough this new framework agreement, it is intended that Kanabo\u2019s VapePod medicinal cannabis formula, under brand NOIDECS will be made available to Project Twenty21 patients. Project Twenty21 provides eligible patients with affordable medical cannabis treatment, monitored by Drug Science. The project aims to create the UK’s largest body of evidence for the effectiveness and tolerability of medical cannabis.\n<\/p>\n

\nThe VapePod will be the first product of its kind, a medical-grade handheld vaporiser with controlled metered dosage, made available to UK cannabis patients with a medical prescription. The initial formula, which Astral Health will distribute under the name NOIDECS 400T, is based on the Israeli medical cannabis pharmacopoeia as a recommended ratio for pain management. Kanabo and Astral Health will work closely together to make the products available to patients over the next 3-6 months.\n<\/p>\n

Avihu Tamir, Kanabo’s CEO commented<\/b>: \u201cWe believe this new product will be revolutionary for medical cannabis patients who need immediate relief of pain, and will replace the smoking of cannabis flowers as a medical delivery method, which is one of Kanabo’s main targets.\u201d<\/i><\/p>\n

Dean Friday, LYPHE\u2019s CEO commented: <\/b>\u201cWe have seen the headlines, and we have witnessed the negative impact of opioids. Pain is not going to go away, so a more natural and caring approach to treating it must find centre stage. Thanks to our partnership with Kanabo we now have a metered dose NOIDECS product that can treat patients across the U.K. that suffer from chronic pain.\u201d<\/i><\/p>\n

\nAbout LYPHE Group:
\n
LYPHE Group, delivers a patient-focused medical cannabis ecosystem, and has emerged as the UK\u2019s market leader in patient care \u2013 seeing over 60% of the medical cannabis patients in the country. LYPHE delivers a reliable and seamless supply of medical cannabis care and medicine. It has built a patient-access ecosystem across the UK that provides clinics, pharmacy & dispensing, import infrastructure and vital educational services to patients, doctors and other health care professionals.\n<\/p>\n

\nAbout Kanabo
\n
Kanabo is a medical cannabis company based in the UK and Israel, provides innovative solutions for the medical cannabis industry. Having built a medically validated IP that includes delivery systems working with patented formulations, Kanabo’s Initial product development is focused on vaporisation, including both medical grade vaporisers and formulations of medical cannabis extracts.\n<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20210223005576\/en\/<\/a><\/span><\/p>\n

\nMichelle Tamir
\n
Kanabo Group Plc
\n
+972 52 317 3633
\n
press@kanabogroup.com
\n<\/a>
www.kanabogroup.com<\/a><\/p>\n

KEYWORDS:<\/b> United Kingdom Europe<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Pharmaceutical Health Medical Supplies<\/p>\n

MEDIA:<\/b><\/p>\n\n","protected":false},"excerpt":{"rendered":"

Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group LONDON–(BUSINESS WIRE)– Kanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited (\u201cAstral Health\u201d). Astral Health is fully owned by LYPHE Group, which is part of Drug Science\u2019s Project Twenty21. According to the agreement, Kanabo will supply its medical-grade inhalation device, VapePod\u00ae and a line of medicinal cannabis formulations in pods for the UK market. Through this new framework agreement, it is intended that Kanabo\u2019s VapePod medicinal cannabis formula, under brand NOIDECS will be made available to Project Twenty21 patients. … <\/p>\n

Continue reading “Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441470","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nNewly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group LONDON–(BUSINESS WIRE)– Kanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited (\u201cAstral Health\u201d). Astral Health is fully owned by LYPHE Group, which is part of Drug Science\u2019s Project Twenty21. According to the agreement, Kanabo will supply its medical-grade inhalation device, VapePod\u00ae and a line of medicinal cannabis formulations in pods for the UK market. Through this new framework agreement, it is intended that Kanabo\u2019s VapePod medicinal cannabis formula, under brand NOIDECS will be made available to Project Twenty21 patients. … Continue reading "Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T10:36:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group\",\"datePublished\":\"2021-02-23T10:36:11+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/\"},\"wordCount\":529,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/\",\"name\":\"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2021-02-23T10:36:11+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/","og_locale":"en_US","og_type":"article","og_title":"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group - Market Newsdesk","og_description":"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group LONDON–(BUSINESS WIRE)– Kanabo Group Plc, a medical cannabis company that recently debuted on London Stock Exchange, is delighted to announce it has signed its first UK medicinal cannabis distribution framework agreement with Astral Health Limited (\u201cAstral Health\u201d). Astral Health is fully owned by LYPHE Group, which is part of Drug Science\u2019s Project Twenty21. According to the agreement, Kanabo will supply its medical-grade inhalation device, VapePod\u00ae and a line of medicinal cannabis formulations in pods for the UK market. Through this new framework agreement, it is intended that Kanabo\u2019s VapePod medicinal cannabis formula, under brand NOIDECS will be made available to Project Twenty21 patients. … Continue reading \"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T10:36:11+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group","datePublished":"2021-02-23T10:36:11+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/"},"wordCount":529,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/","name":"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en","datePublished":"2021-02-23T10:36:11+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20210223005576r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/newly-listed-on-lse-kanabo-group-announces-partnership-with-the-uks-biggest-cannabis-clinic-provider-lyphe-group\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Newly Listed on LSE, Kanabo Group Announces Partnership With the UK\u2019s Biggest Cannabis Clinic Provider, LYPHE Group"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441470"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441470\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}